Scripps Research is a biopharmaceutical and biotechnology startup founded in 1993. The company recently secured a substantial $67.00M grant investment on 18 May 2022 from the National Institute of Allergy and Infectious Diseases. This significant investment reflects the trust and interest of major players in the healthcare and biotech sector, positioning Scripps Research as a potential leader in developing innovative solutions for pertinent global health challenges.
General Information
BounceWatch is an independent company data service, not affiliated with Scripps Research. To contact Scripps Research, visit scripps.edu.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Scripps Research compare?
A PDF of Scripps Research and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Scripps Research soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biopharma
About Scripps Research
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $67.00M | 1 |
National Institute of Allergy and Infectious Diseases
|
18 May 2022 |
Scripps Research Alternatives & Competitors
View All AlternativesThrough innovation led by gene editing, develop breakthrough human therapeutics and benefit the whol...
Developing Only the Medicine That Human Beings Most Hope for
FAQ About Scripps Research
Source: BounceWatch company record for Scripps Research, https://bouncewatch.com/company/scripps-research, updated 26 June 2026. When citing, please name BounceWatch and link this page.